Publication | Closed Access
Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia
60
Citations
44
References
2018
Year
Hematological MalignancyMedicineMalignant Blood DisorderImmunologyNavitoclax ActCancer GeneticsOncologyCell BiologyCancer ResearchMolecular MedicineMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1